Indian Navy Diclofenac Gel & Topical Antibiotic Tender Utter Kannada Karnataka 2026

Tender Overview

Indian Navy invites bids for topical pharmaceutical products: Diclofenac gel 1% Tube of 30 gm, Mupirocin 2% Ointment Tube of 5 gm, Mometasone 0.1% Tube of 10 gm, and Clindamycin Phosphate 1% Topical Gel Tube of 10 gm. Location: UTTARA KANNADA, KARNATAKA - 581121. No BOQ quantity is specified; no estimated value disclosed. Bidder must submit vendor code documents including PAN Card, GSTIN, Cancelled Cheque, and EFT Mandate. The ATC attachment has been uploaded. This procurement focuses on standard topical formulations to support medical logistics for the Navy. The option clause permits quantity changes up to 50% at contract award and during execution at contracted rates, with delivery timelines linked to original delivery periods and extended periods.

Technical Specifications & Requirements

• Product names and potencies as listed above, with tube weights of 30 g (Diclofenac), 5 g (Mupirocin), 10 g (Mometasone), and 10 g (Clindamycin Gel).
• No explicit technical performance metrics or IS/ISO standards stated in the data; bidders should ensure pharmaceutical grade packaging and labeling compliant with general government procurement norms.
• Delivery mechanics tie to the 50% quantity variation clause; delivery period calculation follows (Increase quantity ÷ Original quantity) × Original delivery period, minimum 30 days; extension allowed to the original delivery period.
• Organization requires vendor code creation documents; no BOQ items provided.

Terms, Conditions & Eligibility

• EMD amount not disclosed; bidders must comply with standard vendor code creation documents: PAN Card, GSTIN, Cancelled Cheque, EFT Mandate.
• Option Clause allows quantity variation up to 50% at placement and during currency of contract at the contracted rates.
• Delivery schedule anchored to last date of the respective order; extended delivery time rules apply.
• ATC document uploaded; bidders must adhere to generic procurement terms and submit required financial and regulatory documents.